Literature DB >> 10655309

Zona pellucida damage to human embryos after cryopreservation and the consequences for their blastomere survival and in-vitro viability.

E Van Den Abbeel1, A Van Steirteghem.   

Abstract

The study objective was to quantify zona pellucida (ZP) damage in cryopreserved human embryos. The influence of two different freezing containers was investigated, and the influence of freezing damage on the survival and viability of the embryos evaluated. ZP damage did not differ according to whether embryos originated from in-vitro fertilization (IVF) cycles or from IVF cycles in association with intracytoplasmic sperm injection (ICSI). The freezing container, however, significantly influenced the occurrence of ZP damage after cryopreservation. More damage was observed when the embryos were frozen-thawed using plastic cryovials than using plastic mini-straws (16.6% versus 2.3%; P < 0.0001). A clear association was found between blastomere survival and ZP intactness. Consequently, the percentage of embryos with 100% blastomere survival was higher when embryos were frozen-thawed using plastic mini-straws. The further cleavage of frozen-thawed embryos suitable for transfer was not different whether there was ZP damage or not; however, it was higher when there was 100% blastomere survival as compared with when some blastomeres were damaged (79.0% versus 43.7%; P < 0.0001). Consequently, more embryos suitable for transfer cleaved further when they were frozen-thawed using plastic mini-straws. In conclusion, the aim of a cryopreservation programme should be to have as many fully intact embryos as possible after thawing. Increased ZP damage might indicate a suboptimal cryopreservation procedure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655309     DOI: 10.1093/humrep/15.2.373

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

2.  Effect of laser-assisted hatching and necrotic blastomere removal on the development of vitrified-warmed four-cell mouse embryos.

Authors:  Rouhollah Fathi; Mojtaba Rezazadeh Valojerdi; Poopak Eftekhari-Yazdi
Journal:  J Assist Reprod Genet       Date:  2008-08-08       Impact factor: 3.412

3.  Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women.

Authors:  Dimitra Kyrou; Human M Fatemi; Christophe Blockeel; Dominic Stoop; H Albuarki; Greta Verheyen; Paul Devroey
Journal:  J Assist Reprod Genet       Date:  2010-08-12       Impact factor: 3.412

4.  Impact of cell loss after warming of human vitrified day 3 embryos on obstetric outcome in single frozen embryo transfers.

Authors:  Federica Di Guardo; A Racca; G Coticchio; A Borini; P Drakopoulos; S Mackens; H Tournaye; G Verheyen; C Blockeel; L Van Landuyt
Journal:  J Assist Reprod Genet       Date:  2022-07-20       Impact factor: 3.357

5.  Vitrification of human early cavitating and deflated expanded blastocysts: clinical outcome of 474 cycles.

Authors:  G A Rama Raju; G Jaya Prakash; K Murali Krishna; K Madan
Journal:  J Assist Reprod Genet       Date:  2009-10-30       Impact factor: 3.412

6.  Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3?

Authors:  Dominic Stoop; Lisbet Van Landuyt; Etienne Van den Abbeel; Michel Camus; Greta Verheyen; Paul Devroey
Journal:  Reprod Biol Endocrinol       Date:  2011-05-05       Impact factor: 5.211

7.  Effects of vitrified cryopreservation duration on IVF and neonatal outcomes.

Authors:  Yuling Mao; Ni Tang; Yanfen Luo; Ping Yin; Lei Li
Journal:  J Ovarian Res       Date:  2022-09-08       Impact factor: 5.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.